A man was removed from a flight over his wheelchair aid (Picture: Shane Hryhorec)
A wheelchair user was removed from his flight home over a disability aid after an ‘undignified’ confrontation with
The five teenagers died in the collision on the M9,in County Kildare,on Sunday morning
Five teenagers killed when their stolen BMW ploughed head-on into a family while driving on the wrong side of a
Kamil Pustkowski, Joe Carthy, Alex McCarthy, Jack Kennedy and Jeremy O’Brien sped the wrong way down the M9 in Co Kildare, crashing into a family heading on holiday.
The haul of gold bars and coins was uncovered as workers drilled into the foundations of the building in Dendermonde, Belgium, while installing new sewage pipes.
SYRACUSE,N.Y.,Nov. 19,2024-- In a landscape marked by intense competition,rising costs,and stringent regulatory requirements,independent pharmacies face an array of challenges that threaten their viab
TURFAN,China,Nov. 18,2024-- On November 15,in the transmission safety monitoring center of the State Grid Turfan Power Supply Company,the power supply personnel used the AI real-world monitoring devic
SINGAPORE,Nov. 18,2024--The Singapore Management University(SMU) hosted the third RI-SING University Network (RUN) meeting on 12-13 November 2024,bringing together top educational leaders from Singap
BOLINGBROOK,Ill.,Nov. 18,2024--Stock up your family\'s medicine cabinet this Black Friday and Cyber Monday. WELLlife,a leading innovator in medical diagnostic and testing solutions,is increasing acces
HONG KONG,Nov. 19,2024-- The highly anticipated Hong Kong FashionFest,running from 20 November to 4 December 2024,is set to take over the city with an expansive programme celebrating fashion,creativi
11-19 Cultural and Creative Industries Development Agency (CCIDA)
MELBOURNE,Australia,Nov. 19,2024-- Telix Pharmaceuticals Limited (ASX: TLX; Nasdaq: TLX,Telix,the Company) today announces it will expand its theranostic pipeline with new assets targeting Fibroblast
78-Week results from Phase III randomized controlled trial (RCT) including switching data from reference denosumab to CT-P41 (biosimilar candidate of denosumab) demonstrate comparable efficacy and sa
